Alnylam Pharmaceuticals Appoints Stuart Arbuckle to Board as Mike Bonney and Carolyn Bertozzi Step Down

Reuters
2025.12.03 13:01
portai
I'm PortAI, I can summarize articles.

Alnylam Pharmaceuticals Inc. announced changes to its Board of Directors. Mike Bonney and Carolyn Bertozzi will step down on December 2, 2025. Stuart Arbuckle will join as an independent director on January 5, 2026.

Alnylam Pharmaceuticals Inc. announced that Mike Bonney and Carolyn Bertozzi, Ph.D., will step down from its Board of Directors effective December 2, 2025. Stuart Arbuckle has been appointed as a new independent director, effective January 5, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alnylam Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251203030753) on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer